Tasneem Abaza is an expert in Biochemistry at Egypt-Japan University of Science and Technology (Egypt). Tasneem Abaza has authored 8 publications, the most recent in 2026. SLR score: 44 (community average: 125). How the SLR is computed.

LeadR Profile

44 ScienceLeadR Reputation 44
Network Map

Biochemistry

Subspecialties: Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2020 - 2026

Source: PubMed

Egypt-Japan University of Science and Technology

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 8

Citations

Citations: 77 1st author: 2 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Gasotransmitters in cancer metastasis: insights from the biology of carbon monoxide, nitric oxide, and hydrogen sulfide.
PMID 42775996 — sulfides, protein kinases, gasotransmitters, neoplasms, phosphatidylinositol 3-kinase, neoplasm metastasis
Med Gas Res20260
Emerging role of transfer RNA-derived small RNAs (tsRnas) in hepatocellular carcinoma.
PMID 41353580 — genes, carcinoma, hepatocellular, neoplasms, therapeutics, rna, transfer, rna
Expert Rev Mol Diagn20252
Galectins: a promising arsenal of novel immunotherapeutic weapons in oncology tunned by an array of non-coding RNAs.
PMID 41091576 — biochemistry, galectins, molecular biology, neoplasms, weapons, therapeutics
Crit Rev Biochem Mol Biol20250
Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy.
PMID 40768059 — nanoparticles, neoplasms, immunotherapy, nucleic acids, therapeutics, lipid nanoparticles
Med Oncol20250
Extracellular vesicles: from intracellular trafficking molecules to fully fortified delivery vehicles for cancer therapeutics.
PMID 39823046 — extracellular vesicles, neoplasms, therapeutics
Nanoscale Adv20251

LeadR Networks

Main global connection map